For the first time, Japan has approved the over-the-counter sale of the emergency contraceptive pill, Norlevo, enabling women to obtain it without a prescription. ASKA Pharmaceutical announced this significant development, emphasizing that it will empower women regarding their reproductive health. The pill will be labeled as 'medicine requiring guidance,' meaning it must be taken in the presence of a pharmacist. Previously, access was limited to clinics or pharmacies with a doctor's prescription. The approval follows a public consultation in 2017 that showed strong support for easier access, although officials had previously hesitated due to concerns about potential misuse. The pill is effective within 72 hours after unprotected sex and has an efficacy rate of 80%. This change is seen as a crucial step in addressing the conservative views on women's reproductive rights in Japan.